Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2003
04/24/2003US20030077282 Use of bispecific antibodies to regulate immune responses
04/24/2003US20030077281 Immunointeractive molecules and uses therefor
04/24/2003US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells
04/24/2003US20030077278 Novel human beta2 integrin alpha subunit
04/24/2003US20030077277 Human antibodies that have MN binding and cell adhesion-neutralizing activity
04/24/2003US20030077276 Expression vectors constructed by inserting antibody heavy chain variable region-encoding cDNA and antibody light chain variable region-encoding cDNA isolated from hybridomas producing rat onoclonal antibody reacting with ganglioside gm2
04/24/2003US20030077275 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences
04/24/2003US20030077274 Particularly in high-risk individuals
04/24/2003US20030077273 Methods of treating antibody-mediated pathologies using agents which inhibit CD21
04/24/2003US20030077252 Vaccination against plaque forming diseases; inhibiting aggregation of amyloid in mammal and/or to cause disaggregation of amyloid; treating brain disorder, Alzheimer's disease
04/24/2003US20030077249 DNA coding for one or more recombinant chimeric receptors comprising two or more different cytoplasmic signalling polypeptides; drug delivery system for treating cancer
04/24/2003US20030077246 TNFr/OPG-like molecules and uses thereof
04/24/2003US20030075289 Method and compositions for processing poultry feathers
04/24/2003CA2463943A1 Human antibodies that have mn binding and cell adhesion-neutralizing activity
04/24/2003CA2463931A1 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes
04/24/2003CA2463927A1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
04/24/2003CA2463676A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
04/24/2003CA2463672A1 Direct targeting binding proteins
04/24/2003CA2463634A1 Anti-hla-dr antibody
04/24/2003CA2463492A1 Methods for the treatment of carcinoma
04/24/2003CA2463017A1 Method for preparation of single chain antibodies
04/24/2003CA2463003A1 Dimerized growth factor and materials and methods for producing it
04/24/2003CA2462785A1 Kinases and phosphatases
04/24/2003CA2461818A1 Treatment and diagnosis of insulin resistant states
04/24/2003CA2455899A1 Compositions and methods for the modulation of viral maturation
04/24/2003CA2454578A1 Modified human thymic stromal lymphopoietin
04/23/2003EP1304379A2 Humanised antibody against CD18
04/23/2003EP1304378A1 ARL-2 for fertility control
04/23/2003EP1304375A1 Method of preparing antibody by gene immunization
04/23/2003EP1304336A2 Antibodies for specific detection of pathogenic prions of human origin and detection methods using them
04/23/2003EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction
04/23/2003EP1303611A2 Novel protein containing ring finger domaine r1p4
04/23/2003EP1303609A2 G-protein coupled receptors
04/23/2003EP1303604A2 Mammalian receptor proteins; related reagents and methods
04/23/2003EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
04/23/2003EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it
04/23/2003EP1303540A2 Multi-specific reagent for selective stimulation of cell surface receptors
04/23/2003EP1303539A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
04/23/2003EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use
04/23/2003EP1303534A2 Promyostatin peptides and methods of using same
04/23/2003EP1303303A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
04/23/2003EP1303183A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs
04/23/2003EP1250055A4 Immune modulation with death receptor-induced apoptosis
04/23/2003EP1235842A4 Rna interference pathway genes as tools for targeted genetic interference
04/23/2003EP1117681B1 Rho-cocotoxin peptides having selective alpha-1 adrenoceptor activity
04/23/2003EP1057033B1 Treating cancer
04/23/2003EP1057032B1 Treating cancer
04/23/2003EP1057031B1 Treating cancer
04/23/2003EP1057030B1 Treating cancer
04/23/2003EP1057029B1 Treating cancer
04/23/2003EP1057028B1 Treating cancer
04/23/2003EP1019503A4 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
04/23/2003EP1018009B1 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material
04/23/2003EP0961827A4 Mammalian and human rec2
04/23/2003EP0935754A4 Compositions and methods for detection of antibody binding to cells
04/23/2003EP0906571B1 Labelling and selection of molecules
04/23/2003EP0871654B1 Protegrins
04/23/2003EP0857177B1 Process for the preparation of a single chain fv antibody fragment
04/23/2003EP0840618B1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
04/23/2003EP0726961B1 Diagnosis of mental disorders
04/23/2003EP0714439B1 Recombinant humanized anti-human immunodeficiency virus antibody
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003CN1413249A Human heparanase-related polypeptide and nucleic acid
04/23/2003CN1413220A Anti-prostate stem cell antigen (PSCA) antibody compositions and method of use
04/23/2003CN1413219A Molecular structure of RHD negative genes locus
04/23/2003CN1413195A Immunoassay detection method for neonicotinyl insecticides
04/23/2003CN1412562A Preparation method of reagent for diagnosing cardiac infarction and its active components
04/23/2003CN1412201A Monoclonal antibody for resisting human liver cancer and its application
04/23/2003CN1411798A Safety toothpaste for preventing and curing oral cavity disease
04/23/2003CN1106203C Chlamydia vaccine and process
04/22/2003US6552199 Fluorescence dyes and their use as fluorescence markers
04/22/2003US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof
04/22/2003US6552169 Density enhanced protein tyrosine phosphatases
04/22/2003US6552164 Reagents and methods useful for detecting diseases of the breast
04/22/2003US6552016 For inhibiting aberrant growth states resulting from hedgehog gain- of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule
04/22/2003US6551830 Rh blood group antigen compositions and methods of use
04/22/2003US6551822 NL4 tie ligand homologue
04/22/2003US6551821 Brain cyclic nucleotide gated ion channel and uses thereof
04/22/2003US6551810 Polypeptide retains the ability to dephosphorylate an activated MAP-kinase
04/22/2003US6551808 Desaturase antigen of Mycobacterium tuberculosis
04/22/2003US6551799 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects
04/22/2003US6551792 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
04/22/2003US6551789 Process for characterizing a biological sample using patterns of oncogene expression
04/22/2003US6551775 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1
04/22/2003US6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
04/22/2003US6551599 Monoclonal antibodies against campylobacter jejuni and campylobacter coli outer membrane antigens
04/22/2003US6551594 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
04/22/2003US6551592 Bind at the same time to the T-cell receptor complex, to tumour- associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody
04/22/2003US6551586 Merozoite surface antigen1 (MSA1); vaccinia virus expression vector which expresses a malaria MSA1 peptide in combination with a signal peptide and anchor peptide in a host animal
04/22/2003US6551575 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
04/22/2003US6551495 Electrochemical assays
04/22/2003CA2253636C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
04/22/2003CA2114327C Haptens, tracers, immunogens and antibodies for immunoassays for propoxyphene
04/22/2003CA2098295C G protein-coupled glutamate receptors
04/22/2003CA2096975C Cell stress transcriptional factors
04/22/2003CA2076386C Identification and expression of insect steroid receptor dna sequence
04/22/2003CA2068630C Use of protein c or activated protein c
04/22/2003CA1341427C Variants of immunoglobulin gene superfamily member
04/19/2003CA2408762A1 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
04/17/2003WO2003031942A1 Reagents and methods useful for detecting diseases of the breast
1 ... 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 ... 1494